Literature DB >> 2925413

Clinical neurologic assessment tool: development and testing of an instrument to index neurologic status.

L Crosby1, L C Parsons.   

Abstract

The clinical neurologic assessment tool (CNA) is a 21-item instrument assessing response to verbal and tactile stimulation, ability to follow commands, muscle tone, body position, movement, chewing, and yawning in the patient with head trauma. The CNA was developed to detect subtle changes in the patients' neurologic status that may indicate transitions in the comatose state. The CNA has been extensively pilot tested. Reliability determined by using Cronbach's alpha revealed an internal consistency of 0.96. Concurrent validity testing with the Glasgow Coma Scale indicated a strong positive correlation, r = 0.94. Construct validity was assessed with factor analysis using 0.50 for a loading criterion. Three factors were demonstrated: general level of consciousness, muscle tone and resistance, and chewing or yawning. Discriminant function analysis revealed that the CNA scores correctly classified 95.1% of the patient observations into their respective Glasgow Coma Scale categories. The CNA is reliable, valid, convenient, and easily scored and captures the subtle changes in the patient with head trauma.

Entities:  

Mesh:

Year:  1989        PMID: 2925413

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  3 in total

Review 1.  Evaluation of coma: a critical appraisal of popular scoring systems.

Authors:  Joshua Kornbluth; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 2.  Methodological considerations in the neuropsychological study of central nervous system underarousal with a specific emphasis on coma.

Authors:  D E Stanczak
Journal:  Neuropsychol Rev       Date:  1998-12       Impact factor: 7.444

3.  Validity of the FOUR score coma scale in the medical intensive care unit.

Authors:  Vivek N Iyer; Jayawant N Mandrekar; Richard D Danielson; Alexander Y Zubkov; Jennifer L Elmer; Eelco F M Wijdicks
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.